Abstract: Sarcomatoid change has been well documented in the various subtypes of renal cell carcinoma (RCC) and its presence is known to portend a worse prognosis in RCC. Mucinous tubular and spindle cell carcinoma is a RCC subtype, which is defined as polymorphous histology wherein the spindled epithelial cell is an inherent carcinomatous component. Many of these putatively low-grade tumors have been previously misdiagnosed as unclassified or sarcomatoid papillary RCC. We present 2 examples of hitherto undescribed sarcomatoid change in mucinous tubular and spindle cell carcinoma in a 71-year-old woman and an 80-year-old man who both underwent a radical nephrectomy procedure. In addition to the classic mucinous tubular and spindle cell carcinoma morphology, both cases had a sarcomatoid component characterized by predominantly highgrade spindle cells, solid pleomorphic epithelioid cells, and malignant fibrous histiocytoma-like storiform patterns. Sarcomatoid change comprised 60% and 20% of the tumors, respectively. Unlike the spindle sarcomatoid cells, the inherent spindle cell elements of mucinous tubular and spindle cell carcinoma had distinctively low-grade cytology and occasionally blended with tubular structures and variable mucinous stroma. The sarcomatoid cells were associated with significant necrosis, marked nuclear pleomorphism, mitoses of up to 5/10 high power field, higher proliferation fraction (MIB1), and loss of a-methylacyl-CoA racemase or cytokeratin 7 expression. Cytogenetic analysis in 1 tumor showed loss of chromosomes 14 and 15 and gains of chromosomes 2, 5, 7, 9, 10, 12, 17, 19, 20, 22 , and X. Widespread metastasis to lymph nodes, bones and lungs occurred in one patient who succumbed 9 months after nephrectomy. Helpful features in distinguishing spindle cells of sarcomatoid component versus that of the native tumor include the presence of high-grade cytology, expansile growth with loss of typical imperceptible blending with the tubulo-papillary component, extensive necrosis, high mitotic activity, high proliferation fraction, and loss of expression of a-methylacylCoA racemase that contrasted the classic areas. Distinction of the sarcomatoid histology from inherent spindle cell component of mucinous tubular and spindle cell carcinoma is important because of its unfavorable prognostic implication. M ucinous tubular and spindle cell carcinoma is a newly recognized subtype of renal cell carcinoma (RCC). According to the World Health Organization, mucinous tubular and spindle cell carcinoma is a lowgrade polymorphic renal epithelial neoplasm with mucinous tubular and spindle cell features. 22 Because of the inherent spindle epithelial cell component, many of these mucinous tubular and spindle cell carcinoma tumors were previously diagnosed as sarcomatoid papillary RCC. In fact, the banal-appearing spindle cells of the mucinous tubular and spindle cell carcinoma have also been recently described in papillary RCC.
M
ucinous tubular and spindle cell carcinoma is a newly recognized subtype of renal cell carcinoma (RCC). According to the World Health Organization, mucinous tubular and spindle cell carcinoma is a lowgrade polymorphic renal epithelial neoplasm with mucinous tubular and spindle cell features. 22 Because of the inherent spindle epithelial cell component, many of these mucinous tubular and spindle cell carcinoma tumors were previously diagnosed as sarcomatoid papillary RCC. In fact, the banal-appearing spindle cells of the mucinous tubular and spindle cell carcinoma have also been recently described in papillary RCC. 1 Currently, there are no more than 80 examples of mucinous tubular and spindle cell carcinoma reported in the literature. 2, [5] [6] [7] [8] 10, 12, 13, [15] [16] [17] [18] 21, 23, 24 In most of these cases, typical tumor histology includes tubules lined by low-grade cuboidal cells and banal-appearing spindle shaped cells in a variable myxoid stroma. 17, 24 Histologic variations such as mucin-poor histology and presence of focal papillations can occur in mucinous tubular and spindle cell carcinoma. 6 Very few cases have demonstrated recurrence, 18 metastasis to regional lymph nodes at the time of presentation, 7, 23 and distant metastases. 23 Sarcomatoid change in RCC has an overall incidence of 8% and is well documented to occur in the more common subtypes of RCC. 25 RCC with even a small sarcomatoid component may have an adverse outcome, such that presence of sarcomatoid change must be documented in the pathology report for RCC. 25 Herein, we present 2 examples of hitherto undescribed mucinous tubular and spindle cell carcinoma with sarcomatoid change, including 1 patient who developed widespread tumor metastasis. Our goal is to highlight helpful histomorphologic and immunohistochemical differences of the sarcomatoid areas from the inherent spindle epithelial cell component of mucinous tubular and spindle cell carcinoma.
CASE REPORTS Case 1
A 71-year-old woman presented with a 5-month history of back pain. Computed tomography scan showed an 8 cm heterogeneous mass in the superior pole of the left kidney. There was associated multiple abdominal and retroperitoneal lymphadenopathy. Extended computed tomography scan revealed expansile lytic lesions which involved the right and the left ribs, lumbar 4 vertebral body and multiple bilateral lung nodules, the largest of which measured 1.1 cm in diameter. The patient underwent a radical nephrectomy and a wedge biopsy of one of the lung nodules. The patient died 9 months after the nephrectomy.
The nephrectomy specimen had a 9.5 Â 8.5 Â 6.8 cm predominantly cortical-based poorly circumscribed tumor extending to the medulla and focally into the renal sinus (Fig. 1) . No perinephric fat extension was identified grossly. The tumor was variegated tan, yellow, and white, and extensively necrotic. Morphologically, the tumor showed typical areas of mucinous tubular and spindle cell carcinoma comprising approximately 40% of the tumor ( 
Case 2
An 80-year-old man with a history of chronic obstructive lung disease presented with an 11 cm left kidney tumor. Radiographic studies for metastatic disease were negative. The patient underwent a radical nephrectomy and had no evidence of tumor recurrence or metastasis after 4 months of follow-up.
Grossly, the tumor was partially demarcated by a discrete pseudocapsule and focally had infiltrative irregular borders. The tumor was extensively necrotic (approximately 70%). Morphologically, the viable area of the tumor showed a predominantly mucin-poor mucinous tubular and spindle cell carcinoma composed of bland appearing tubules and arrays of spindle cells (Fig. 9 ). There were occasional tubulo-papillary structures variably lined by clear cells and psammoma bodies. Approximately 20% of the tumor was composed of a high-grade spindle cell sarcoma that merged with areas of low-grade tubular and spindled mucinous tubular and spindle cell carcinoma cells. The sarcomatoid component also showed pseudovascular and MFH-like storiform patterns similar to those observed in case 1. The sarcomatoid areas showed significant tumor necrosis associated with variable amount of desmoplastic stroma. The sarcomatoid spindle cells had large pleomorphic nuclei and variably prominent nucleoli (Fig. 10) . The background stroma was at places myxoid. Focally, tubules lined by clear cells were identified within the sarcomatoid areas. Mitoses were low in the sarcomatoid components (0-1/10 high power fields). Both the low-grade tubular and spindle cells of the classic mucinous tubular and spindle cell carcinoma showed strong cytoplasmic reactivity to CK7 and a-methylacyl-CoA racemase (AMACR). In contrast, the spindle cell sarcomatoid component did not express CK7 or AMACR.
DISCUSSION
Sarcomatoid change has been well documented in the more common subtypes of RCC, papillary RCC, chromophobe RCC, and collecting duct carcinoma. 25 In a previous study, when compared with a cohort of RCC without sarcomatoid change, RCC with sarcomatoid change tended to present at a more advanced stage. 25 Patients with sarcomatoid change had a worse prognosis than did patients without sarcomatoid change. 25 Due to the unfamiliarity with this novel tumor type, many mucinous tubular and spindle cell carcinoma cases had previously been diagnosed as RCC with sarcomatoid change, particularly sarcomatoid papillary RCC, basophilic type, or type 2. 25 Recently, nonsarcomatoid lowgrade spindle cells were also described in papillary RCC mimicking mucinous tubular and spindle cell carcinoma. 1 As case 2 in this series was predominantly mucin poor, it may raise a question of possible solid variant of papillary RCC. However, the presence of typical mucin-rich areas, although focal, argues against this diagnosis of papillary RCC. Furthermore, the absence of micronodules present within the solid sheets of cells makes this diagnosis less likely. Hence, we interpret that case 2 is a mucinous tubular and spindle cell carcinoma. Thus far, only few cases of mucinous tubular and spindle cell carcinoma with follow-up reported tumor recurrence and metastasis 7, 18, 23 suggesting a low-grade behavior for this tumor type. Thus, pathologic distinction of mucinous tubular and spindle cell carcinoma from RCC with sarcomatoid change is imperative with important prognostic ramification. Herein, we present 2 cases of mucinous tubular and spindle cell carcinoma, which exhibited frank sarcomatoid change, in addition to the typical low-grade spindle cells of mucinous tubular and spindle cell carcinoma. These cases thereby extend the spectrum for the occurrence of sarcomatoid change in RCC subtypes to include mucinous tubular and spindle cell carcinoma.
Banal-appearing spindle cells are an inherent defining component of mucinous tubular and spindle cell carcinoma. 17, 24 The presence of these benign-appearing spindle cells does not give a bad prognosis to this carcinoma. Sarcomatoid change in RCC has a worse prognosis and is defined histologically by the presence of spindle cells with nuclear pleomorphism and prominent nucleoli. 3, 19, 20 These cytologic changes were observed in both of our cases. The sarcomatoid cells were pleomorphic, had prominent nucleoli, mitotic figures, and areas of necrosis, in addition to the various architectural patterns as we have described above. These features were associated with an adverse prognosis as demonstrated by distant metastases and death in one of our cases. This is in striking contrast to the favorable prognosis of patients with mucinous tubular and spindle cell carcinoma, which is considered to be a low-grade carcinoma.
The sarcomatoid components in the more common RCC with sarcomatoid change oftentimes resemble fibrosarcoma, MFH, undifferentiated sarcoma and rarely, heterologous elements such as rhabdomyosarcomatous differentiation. 25 In the 2 cases of mucinous tubular and spindle cell carcinoma presented herein, the sarcomatoid Distinction between the inherent spindled epithelial components of mucinous tubular and spindle cell carcinoma from the bona fide sarcomatoid spindle cell component can be challenging, particularly in a limited biopsy specimen. In these 2 cases of sarcomatoid mucinous tubular and spindle cell carcinoma, we observed certain differences in the cytologic, architectural, and immunohistochemical features of the low-grade and sarcomatoid spindle cell areas. The inherent spindle cell component of mucinous tubular and spindle cell carcinoma is typically low-grade, arranged in parallel arrays blending with elongated tubular cells and well-formed tubules and is associated with variable amounts of stromal mucin. Nuclei are relatively regular and mitoses are very rare in the inherent spindle cell component of mucinous tubular and spindle cell carcinoma. In contrast, the sarcomatoid spindle cells display high-grade cytology including marked nuclear pleomorphism, higher mitotic activity, absence of tubular structures, expansile growth, variable myxoid background ranging from absent to minimal and widespread associated extensive necrosis. In addition, unusual patterns not described in spindle cells of classic mucinous tubular and spindle cell carcinoma were observed including MFH-like and pseudovascular areas and transformation into solid pleomorphic epitheloid and clear cell areas. In our view, these morphologic features are helpful to differentiate between low-grade spindle cell component and sarcomatous change in mucinous tubular and spindle cell carcinoma. MIB1 immunohistochemistry may also be helpful as shown in case 1. There is a striking disparity in the nuclear MIB1 expression between the spindle cells of the classic mucinous tubular and spindle cell carcinoma and the sarcomatoid areas, the latter demonstrated labeling as high as 46%. Interestingly, in 1 tumor (case 2), the classic mucinous tubular and spindle cell carcinoma spindle cells strongly expressed AMACR and CK7, similar to the tubular component but were distinctively absent in the sarcomatoid areas.
Cytogenetic analysis done in case 1 shows gains of chromosomes in addition to the loss of chromosomes. Since mucinous tubular and spindle cell carcinoma is typically associated with chromosome losses, 4, 9, 11, 14, 18 it is reasonable to suggest that the gains of chromosomes identified in this case may represent secondary genetic events associated with sarcomatoid transformation and more aggressive behavior.
In summary, we present the first reported instances of sarcomatoid change in mucinous tubular and spindle cell carcinoma. Features seen only in sarcomatoid spindle areas include presence of high-grade morphology, unusual architectural patterns, extensive necrosis, increased mitotic rate, expansile growth, high proliferation fraction, and distinctively absent expression of mucinous tubular and spindle cell carcinoma-associated marker (AMACR) compared with the inherent spindle cell component of mucinous tubular and spindle cell carcinoma. Presence of these features should be helpful in the distinction of sarcomatoid change in mucinous tubular and spindle cell carcinoma. Identification of sarcomatoid change that may occur in mucinous tubular and spindle cell carcinoma is important because of its potential for aggressive biologic behavior.
